INT8389
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
However, little is known regarding the localization of 26RFa receptors. | |||||||||||||||
| |||||||||||||||
|
In contrast, NMDA dose dependently stimulated neuropeptide FF release, even in the presence of the Na+ channel blocker, tetrodotoxin (1 microM), suggesting that NMDA receptors involved in the release of neuropeptide FF are mainly located on nerve terminals. | |||||||||||||||
| |||||||||||||||
|
Dual localization of neuropeptide FF receptors in the rat dorsal horn. | |||||||||||||||
| |||||||||||||||
|
This study examined the effects of glutamate receptor agonists on the release of neuropeptide FF-like immunoreactivity from rat spinal dorsal half slices. | |||||||||||||||
| |||||||||||||||
|
Modulation of neuropeptide FF release from rat spinal cord slices by glutamate. | |||||||||||||||
| |||||||||||||||
|
In contrast, NMDA dose dependently stimulated neuropeptide FF release, even in the presence of the Na+ channel blocker, tetrodotoxin (1 microM), suggesting that NMDA receptors involved in the release of neuropeptide FF are mainly located on nerve terminals. | |||||||||||||||
| |||||||||||||||
|
The results presented in this study demonstrate that neurokinin A, neuropeptide K and neurokinin B can be released by depolarizing stimuli from rat substantia nigra. | |||||||||||||||
| |||||||||||||||
|
These results show that partial nerve injury to the sciatic nerve induces increases in the content of galanin, neuropeptide Y and calcitonin gene-related peptide immunoreactivities in synaptic terminals within the gracile nucleus, which suggests that there may be increased release of these neuropeptides following sensory or spontaneous stimulation of large-diameter primary afferents following partial nerve injury, perhaps one mechanism involved in neuropathic pain. | |||||||||||||||
| |||||||||||||||
|
Furthermore, immunoneutralization of neuropeptide FF increases endogenous and exogenous opioid-induced analgesia. | |||||||||||||||
| |||||||||||||||
|
Ultrastructural localization of increased neuropeptide immunoreactivity in the axons and cells of the gracile nucleus following chronic constriction injury of the sciatic nerve. | |||||||||||||||
| |||||||||||||||
|
Depolarization induces a Ca2+-dependent release of neuropeptide FF immunoreactivity from the spinal cord. | |||||||||||||||
| |||||||||||||||
|
Neuropeptide FF (NPFF), a morphine modulatory peptide, is localized within discrete autonomic regions including the brainstem nucleus tractus solitarius (NTS) and the parabrachial nucleus (PBN). | |||||||||||||||
| |||||||||||||||
|
The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord. | |||||||||||||||
| |||||||||||||||
|
The present work was to explore if beyond neuropeptide release, cisplatin at a treatment schedule attaining sensory neuropathy, produced changes in the expression of the receptors of sensory neuropeptides such as somatostatin, calcitonin gene-related peptide (CGRP) and substance P (SP) in bronchial tissue of the rat. | |||||||||||||||
| |||||||||||||||
|
An attenuated neurogenic broncho-constriction underpinned by a decrease in sensory neuropeptide release has been shown to be characteristic of cisplatin-induced neuropathy. | |||||||||||||||
| |||||||||||||||
|
Activation of TRPV-1 leads to the release of the proinflammatory neuropeptide substance P (SP). | |||||||||||||||
| |||||||||||||||
|
OBJECTIVE: To investigate the regulatory effects of nerve growth factor (NGF) on basal and capsaicin-induced release of neuropeptide substance P (SP) in primary cultured embryonic rat dorsal root ganglion (DRG) neurons. | |||||||||||||||
| |||||||||||||||
|
Ultrastructural localization of neuropeptide FF, a new neuropeptide in the brain and pituitary of rats. | |||||||||||||||
| |||||||||||||||
|
Ultrastructural localization of neuropeptide FF, a new neuropeptide in the brain and pituitary of rats. | |||||||||||||||
| |||||||||||||||
|
CONCLUSION: SP, a neuropeptide secreted from sensory nerve endings, has been implicated in the pathophysiology of pain and has been shown to trigger MC secretion. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.